AJP - Regu Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Regul Integr Comp Physiol 274: R864-R867, 1998;
0363-6119/98 $5.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Harrison, A. P.
Right arrow Articles by Clausen, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Harrison, A. P.
Right arrow Articles by Clausen, T.
Vol. 274, Issue 3, R864-R867, March 1998

RAPID COMMUNICATION
Thyroid hormone-induced upregulation of Na+ channels and Na+-K+ pumps: implications for contractility

A. P. Harrison and T. Clausen

Department of Physiology, University of Aarhus, 8000 Århus C, Denmark

    ABSTRACT
Top
Abstract
Introduction
Methods
Results
Discussion
References

We have previously observed in rat soleus muscle that endurance is a function of the ratio between the concentration of Na+ channels and Na+-K+ pumps [Harrison, A. P., O. B. Nielsen, and T. Clausen. Am. J. Physiol. 272 (Regulatory Integrative Comp. Physiol. 41): R1402-R1408, 1997]. In this study we explore this relationship further by comparing the changes in Na+ channel and Na+-K+ pump concentrations induced by injections of 3,5,3'-triiodothyronine (T3) with endurance. T3 induced upregulation of the concentration of Na+ channels and Na+-K+ pumps, which was associated with a progressive loss of contractile endurance. The increase in Na+ channels preceded that of the Na+-K+ pumps and amounted to 49 and 52% (both P < 0.01) after 48 and 72 h of T3 treatment, respectively. Concomitantly, during 90-Hz stimulation, the initial rate of force decline increased by 42 and 45% after 48 and 72 h of T3 treatment, respectively (both P < 0.001). These observations are important for an understanding of the fatigue associated with hyperthyroidism and add further support to the hypothesis that muscle endurance depends on the leak-to-pump ratio for Na+.

[3H]ouabain binding; [3H]saxitoxin binding

    INTRODUCTION
Top
Abstract
Introduction
Methods
Results
Discussion
References

SKELETAL MUSCLE IS ONE of the major target tissues for the action of thyroid hormones, of which most of the effects can be ascribed to the action of 3,5,3'-triiodothyronine (T3). Hyperthyroid patients complain of muscle wasting, cramps, muscle weakness, and fatigue, symptoms that disappear when individuals are returned to a euthyroid state (16). It is well established that hyperthyroidism leads to marked upregulation of the concentration of Na+-K+ pumps in skeletal muscle of animals (1, 2, 6) and humans (12). This appears to run contrary to the finding that hyperthyroidism is associated with muscle weakness and fatigue. Rather it should be expected that muscles from hyperthyroid individuals exhibit an enhanced contractile performance associated with improved maintenance of membrane excitability resulting from upregulation of Na+-K+ pump concentration. Evidence that the solution to this problem may lie in another direction was suggested by the findings that 1) within 48 h of T3 treatment Na+ influx at rest is increased in rat skeletal muscle (6), 2) administration of thyroid hormone leads to upregulation of voltage-dependent Na+ channels in cultured myotubes (3), and 3) increased Na+ influx via Na+ channels relative to the capacity for Na+-K+ pumping induces a considerable decrease in the contractile performance of rat soleus muscle (10). This study has therefore sought to address 1) whether administration of T3 induces upregulation of Na+-channel concentration in skeletal muscles in vivo, 2) whether such effects of T3 can be related to an upregulation of Na+-K+ pumps, and 3) whether changes in the concentration of Na+ channels induced by T3 can be related to the impairment of contractile performance associated with hyperthyroidism. Part of these results have been presented as a preliminary communication (9).

    METHODS
Top
Abstract
Introduction
Methods
Results
Discussion
References

Animals and Muscle Preparation

Wistar rats, 4 (60-70 g) or 10 wk old (200 g), were used. Animals of similar body weight from within the same litter were randomly assigned to either a control or T3 group. They were fed a standard rat feed (Altromin Nr. 1314; Spezialfutterwerke, Lage, Germany) ad libitum, and water was freely available. Environmental temperature was maintained at 21°C, and lighting was on a 12:12-h light-dark cycle. Rats were killed by decapitation, and intact soleus muscles were excised as described previously (13). Muscles were placed in a standard incubation medium, Krebs-Ringer bicarbonate buffer, containing (in mM) 120.1 NaCl, 25 NaHCO3, 4.7 KCl, 1.2 KH2PO4, 1.2 MgSO4, 1.3 CaCl2, and 5.0 D-glucose. The buffer was kept at 30°C and equilibrated continuously with a mixture of 95% O2 and 5% CO2 (pH 7.3).

Thyroid Hormones

A T3 solution (40 mM) was prepared in a solvent of 154 mM NaCl containing 1% wt/vol bovine serum albumin, titrated with 2 N NaOH to a final pH of 10-11, as described previously (6). Injections were given once daily at 0900 subcutaneously at a dose rate of 0.2 µg/g body wt, and control rats received an equal volume of the solvent. As described in detail elsewhere, this treatment leads to hyperthyroidism, as evident from an increased heart-to-body weight ratio and a rise in body temperature (6). In the 4-wk-old rats, an initial booster dose of T3 (0.4 µg/g body wt) was administered on the first day to induce rapid onset of hyperthyroidism.

[3H]Saxitoxin Binding

The concentration of Na+ channels was determined as the specific displaceable [3H]saxitoxin binding capacity (8). As previously described in detail (10), intact muscles or strips of muscles weighing 20-38 mg were incubated for 2 h at 4°C in Krebs-Ringer bicarbonate buffer containing [3H]saxitoxin (0.05 µCi/ml) and unlabeled saxitoxin at a final concentration of 2.5 × 10-8 M. After incubation, the muscles were blotted, weighed, and soaked overnight in 2 ml of 300 mM trichloroacetic acid (TCA). The content of [3H]saxitoxin in the TCA extracts was determined by scintillation counting after addition of 2.5 ml of optifluor. For each muscle or strip of muscle, specific uptake of [3H]saxitoxin was measured by incubation in 2.5 × 10-8 M saxitoxin. The unspecific uptake of [3H]saxitoxin was determined after incubation at a final supersaturating concentration of 2.0 × 10-6 M unlabeled saxitoxin. Use of higher concentrations of unlabeled saxitoxin or 2.0 × 10-6 M unlabeled tetrodotoxin for displacement of [3H]saxitoxin gave comparable results for unspecific uptake. Specific displaceable [3H]saxitoxin binding was calculated as the difference between total [3H]saxitoxin uptake and the unspecific uptake of [3H]saxitoxin using the specific activity of [3H]saxitoxin in the buffer and expressed as picomoles per gram wet weight.

[3H]Ouabain Binding

The concentration of Na+-K+ pumps was determined as the specific displaceable [3H]ouabain binding capacity (15). After testing for contractile performance, muscles were frozen in liquid N2 and cut into segments weighing 2-8 mg, washed, and incubated in a buffer of the following composition (in mM): 10 tris(hydroxymethyl)aminomethane (Tris), 3 MgSO4, 1 Tris-vanadate, and 250 sucrose, pH 7.2-7.4. Muscle samples were equilibrated for 2 h at 37°C in buffer containing [3H]ouabain (0.6 µCi/ml) and unlabeled ouabain at a final concentration of 10-6 M. This was followed by four 30-min washes in ice-cold ouabain-free buffer to remove [3H]ouabain not bound to the receptors. The muscle samples were then blotted, weighed, and soaked overnight in minivials containing 0.5 ml 300 mM TCA with 0.1 mM ouabain, added to serve as a carrier, before addition of 2.5 ml optifluor and liquid scintillation counting of the [3H]activity. On the basis of the specific activity of [3H]ouabain in the incubation medium, the amount of [3H]ouabain taken up and retained in the samples was calculated and corrected for nonspecific uptake, loss during washout at 0°C, isotopic purity, and incomplete saturation by multiplying by a comprehensive correction factor of 1.334 (for details see Ref. 11). Measurement of [3H]ouabain binding capacity was done in quadruplicate.

Force Development

As previously described (4, 10), muscles were mounted vertically with their tendons intact in thermostatically controlled chambers and were stimulated directly by supramaximal pulses (10 V, 1-ms duration) through two platinum electrodes. Isometric force development was measured using force displacement transducers (Grass Instruments, Quincy, MA), and recordings were made with a calibrated chart recorder and computer-based recording system (ADInstruments, Hastings, UK). Adjustments to muscle length were made to ensure that maximal isometric force was achieved on stimulation, after which muscles were tested by stimulation at 2, 30, and 90 Hz for 1.5-s duration before being left to equilibrate for 30 min without stimulation. Before the start of the experiment, muscles were stimulated once at 90 Hz for 1.5 s to check contractile force and left to rest for 10 min. The ratio between twitch and tetanic force was 1:5. In all experiments, endurance was examined by recording the decline in contractile force during a period of constant stimulation at 90 Hz until ~80% of initial force had been lost. This parameter, which is effectively the inverse of what is often referred to as fatigue, avoids confusion associated with the precise definition of fatigue, which can occur at the level of the central nervous system, peripheral nervous system, and neuromuscular junction, as well as at the level of the muscle fiber. Endurance was measured as the time taken for peak isometric force to decline by 75%. Contractile force was expressed in Newtons per gram wet weight, and the relative decline of force was calculated as a percentage of the maximum isometric force, which was reached ~1 s after the onset of stimulation. The initial rate of force decline was determined as the relative decrease over the following 30 s.

Chemicals and Isotopes

All chemicals used were of analytic grade. [3H]ouabain (15 Ci/mmol) and [3H]saxitoxin (39 Ci/mmol) were obtained from Amersham International, Buckinghamshire, UK. All other chemicals were obtained from Sigma Chemical.

Statistical Analysis

Differences between means were tested for statistical significance using an unpaired t-test. Differences showing a P value >0.05 were considered nonsignificant (NS). Data are means ± SE.

    RESULTS
Top
Abstract
Introduction
Methods
Results
Discussion
References

Effects of T3 Over 24, 48, or 72 h on 4-Wk-Old Rats

Body weight, muscle weight, and maximum isometric force. Body weights of 4-wk-old rats injected with T3 for 24, 48, and 72 h were reduced by 4-5% in comparison with those of sham-injected controls (P < 0.05). Soleus muscles taken from 4-wk-old control rats weighed 20.5 ± 0.9 mg wet wt (n = 13), a value that was not significantly affected by T3 injection over 24, 48, or 72 h. Moreover, T3 injection over 24, 48, or 72 h did not significantly affect maximum isometric tetanic force (16.2 ± 0.5 N/g wet wt; n = 22) compared with controls (16.5 ± 1.1 N/g wet wt; n = 13).

Muscle endurance. Figure 1 shows the effect of T3 treatment for 48 h on contractile performance of soleus muscles from 4-wk-old rats. During sustained 90-Hz stimulation, the time taken for peak isometric force to decline by 75% was reduced from 3.27 to 2.20 min, a 33% reduction in endurance (P < 0.001). Furthermore, after 72 h of T3 treatment, a similar reduction in endurance (30%; P < 0.01) was found, whereas 24 h of T3 treatment produced a smaller (19%; P = 0.02) decrease in endurance.


View larger version (15K):
[in this window]
[in a new window]
 
Fig. 1.   Time course of decline in isometric force in soleus muscles from control (open circle ) and 48-h 3,5,3'-triiodothyronine (T3)-treated (bullet ) 4-wk-old rats during continuous electrical stimulation at 90 Hz, applied until ~80% of maximum force was lost. T3 was administered subcutaneously (0.4 µg · day-1 ·  · g body wt-1 on day 1 and 0.2 µg · day-1 · g body wt-1 on day 2) while controls were sham injected with an equal volume of the solvent. Endurance, defined as the time taken for peak isometric force to decline by 75%, was measured by reading the intercept of the dashed line with the curve showing force decline off the x-axis. Force decline curves for soleus muscles from control and 48-h T3-treated rats can be fitted by single-exponential equations: y = exp(-0.42x + 4.51), r = 0.98, and y = exp(-0.60x + 4.52), r = 0.99, respectively. Each point represents mean ± SE (vertical lines) of observations on 8-18 muscles. * P < 0.001; dagger  P < 0.01; ddager  P < 0.05 compared with mean of controls (unpaired t-test).

[3H]saxitoxin, [3H]ouabain binding, and initial rate of force decline. Figure 2 shows the time course of the effects of T3 on Na+ channels, Na+-K+ pumps, and the initial rate of force decline. Twenty-four hours after the onset of T3 treatment, there was no change in Na+ channel or Na+-K+ pump concentration. After 48 and 72 h of T3 treatment, Na+-channel concentration increased by 49% (n = 9; P < 0.01) and 52% (n = 8-9; P < 0.01), respectively. Over the first 48 h of T3 treatment, Na+-K+ pump concentration increased by only 8% and did not become significantly different from control levels until after 72 h (28% increase, n = 6-8; P < 0.001). In muscles from T3-treated rats, the initial rate of force decline over the first 30 s of 90-Hz stimulation was 0.88 ± 0.04 (n = 9), 1.11 ± 0.06 (n = 8), and 1.13 ± 0.07 %/s (n = 8) after 24, 48, and 72 h of T3 treatment, respectively, compared with 0.78 ± 0.03 %/s (n = 18) for controls. Thus, after 48 and 72 h of T3 treatment, the rate of force decline in soleus was already significantly faster than that of control muscles after only 30 s of stimulation (42 and 45%, respectively; both P < 0.001). No further significant increase was seen between 48 and 72 h of T3 treatment.


View larger version (18K):
[in this window]
[in a new window]
 
Fig. 2.   Time course of the effects of T3 on Na+ channels (square ), Na+-K+ pumps (black-square), and initial rate of force decline (open circle ) during the first 30 s of 90-Hz stimulation in soleus muscles of 4-wk-old rats. Na+-channel and Na+-K+ pump concentrations were determined using [3H]saxitoxin and vanadate-facilitated [3H]ouabain binding, respectively. T3 was administered subcutaneously (0.4 µg · day-1 · g body wt-1 on day 1 and 0.2 µg · day-1 · g body wt-1 thereafter) for either 24, 48, or 72 h. Controls were sham injected with an equal volume of the solvent. Each point represents mean ± SE (vertical lines) of observations on 5-9, 4-8, and 8-18 muscles for the concentration of Na+ channels, Na+-K+ pumps, and initial rate of force decline, respectively. For details concerning the significance of differences with duration of treatment see METHODS.

Effects of T3 Over 8 Days on 10-Wk-Old Rats

T3 injections were given over 8 days to adult rats (10 wk old) to assess the effects on Na+ channels, Na+-K+ pumps, and muscle performance of a stable period of hyperthyroidism. Body weights of controls and rats injected with T3 for 8 days were not significantly different. However, in soleus muscle significant increases in Na+-channel and Na+-K+ pump concentration, greater than those seen in 4-wk-old rats, were observed. As shown in Table 1, T3 treatment for 8 days produced almost the same relative increase in Na+-channel concentration (154%) and Na+-K+ pump concentration (144%). These changes were associated with a 36% reduction in endurance and a 53% increase in the initial rate of force decline.

                              
View this table:
[in this window]
[in a new window]
 
Table 1.   Effects of 8 days of T3 treatment on the concentration of Na+ channels, Na+-K+ pumps, contractile endurance, and initial rate of force decline in soleus muscles from 10-wk-old rats

    DISCUSSION
Top
Abstract
Introduction
Methods
Results
Discussion
References

Thyroid Hormone Effects on [3H]Saxitoxin and [3H]Ouabain Binding

In rat myotubes in culture, thyroid hormones have been found to induce a 95% increase in Na+-channel concentration within 24 h of treatment (3). The present results extend these observations by showing that T3 in vivo also leads to upregulation of Na+-channel concentration in skeletal muscle. It is interesting that this upregulation of Na+ channels reaches statistical significance before that of the Na+-K+ pumps. This lends further support to the idea that the effect of T3 on the concentration of Na+-K+ pumps should be regarded as an adaptation to the enhanced passive ion leaks (17), where demand for ion transport provides the primary drive for Na+-K+ pump synthesis. We therefore suggest that the upregulation of Na+-K+ pumps associated with hyperthyroidism is the result of the increased resting Na+ influx induced by T3 treatment (6), as well as an increased excitation-induced Na+ influx in working muscles via newly synthesized Na+ channels.

Muscle Contractile Performance and Hyperthyroidism

For over 160 years muscle weakness and fatigue have been identified as symptoms of hyperthyroidism (16), along with muscle wasting and an elevated metabolic rate (5, 14). T3 injection either over a period of only 48-72 h or for a longer period of 8 days led to a loss of endurance of soleus muscles in 4-wk-old rats or mature 10-wk-old rats, respectively, and a faster initial rate of force decline during periods of sustained high-frequency stimulation (Fig. 1 and Table 1). These findings are in agreement with those of others who have shown that in rats T3 treatment increases fatigue (7), defined as a greater decay in force during contraction in hyperthyroid rats compared with euthyroid controls. Furthermore, this study shows that the initial rate of force decline with the onset of hyperthyroidism (Fig. 2) is correlated with the increase in Na+-channel concentration. This observation lends further support to our earlier results (10) indicating that Na+ influx via Na+ channels relative to the capacity for Na+-K+ pumping is an important determinant of the contractile performance of skeletal muscles. The results strongly suggest that the reduced endurance and increased initial rate of force decline induced by T3 are due to a faster decline in the gradient for Na+ arising from increased Na+ influx via an increased concentration of Na+ channels.

Physiological Perspectives

During periods of hyperthyroidism, upregulation of Na+-channel concentration precedes that of Na+-K+ pumps. Furthermore, upregulation of Na+-channel concentration with hyperthyroidism is involved in the faster rate of force decline and loss of endurance that is symptomatic of the disease. These results are important for the understanding of muscle contractile performance experienced by hyperthyroid patients and, in a more general fashion, indicate that the excitation-induced decline in the transmembrane gradient for Na+ during exercise contributes significantly to muscle fatigue.

    ACKNOWLEDGEMENTS

The authors thank Ann-Charlotte Andersen, Tove Lindahl Andersen, Ebba de Neergaard, and Marianne Stürup-Johansen for technical assistance.

    FOOTNOTES

This study was supported by grants from the Biomembrane Research Centre of the University of Aarhus and the Danish Medical Research Council (j.nr. 12-1336).

Address for reprint requests: A. P. Harrison, Dept. of Physiology, Univ. of Aarhus, Universitetsparken, DK-8000 Århus C, Denmark.

Received 20 October 1997; accepted in final form 23 December 1997.

    REFERENCES
Top
Abstract
Introduction
Methods
Results
Discussion
References

1.   Asano, Y., U. A. Liberman, and I. S. Edelman. Thyroid thermogenesis: relationships between Na+-dependent respiration and Na-K adenosine triphosphatase activity in rat skeletal muscle. J. Clin. Invest. 57: 368-379, 1976.

2.   Biron, R., A. Burger, A. Chinet, T. Clausen, and R. Dubois-Ferriere. Thyroid hormones and the energetics of active sodium-potassium transport in mammalian skeletal muscles. J. Physiol. (Lond.) 297: 47-60, 1979[Abstract/Free Full Text].

3.   Brodie, C., and S. R. Sampson. Characterization of thyroid hormone effects on Na channel synthesis in cultured skeletal myotubes: role of Ca2+. Endocrinology 125: 842-849, 1989[Abstract].

4.   Clausen, T., and M. E. Everts. K+-induced inhibition of contractile force in rat skeletal muscle: role of active Na+-K+ transport. Am. J. Physiol. 261 (Cell Physiol. 30): C799-C807, 1991[Abstract/Free Full Text].

5.   Everts, M. E. Effects of thyroid hormones on contractility and cation transport in skeletal muscle. Acta Physiol. Scand. 156: 325-333, 1996[Medline].

6.   Everts, M. E., and T. Clausen. Effects of thyroid hormone on Na+-K+ transport in resting and stimulated rat skeletal muscle. Am. J. Physiol. 255 (Endocrinol. Metab. 18): E604-E612, 1988[Abstract/Free Full Text].

7.   Everts, M. E., W. S. Simonides, W. J. Leijendekker, and C. van Hardeveld. Fatigability and recovery of rat soleus muscle in hyperthyroidism. Metabolism 36: 444-450, 1987[Medline].

8.   Hansen Bay, C. M., and G. R. Strichartz. Saxitoxin binding to sodium channels of rat skeletal muscles. J. Physiol. (Lond.) 300: 89-103, 1980[Abstract/Free Full Text].

9.   Harrison, A. P., and T. Clausen. Muscle fatigue with hyperthyroidism: the importance of Na+ channel concentration relative to that of the Na+-K+ pump. (Abstract) J. Physiol. (Lond.) 504: 230P, 1997.

10.   Harrison, A. P., O. B. Nielsen, and T. Clausen. The role of Na+-K+ pump and Na+-channel concentrations in the contractility of rat soleus muscle. Am. J. Physiol. 272 (Regulatory Integrative Comp. Physiol. 41): R1402-R1408, 1997[Abstract/Free Full Text].

11.   Kjeldsen, K. Complete quantification of the total concentration of rat skeletal-muscle Na+ + K+-dependent ATPase by measurements of [3H]ouabain binding. Biochem. J. 240: 725-730, 1986[Medline].

12.   Kjeldsen, K., A. Nørgaard, C. O. G<A><AC>t</AC><AC>&cjs1134;</AC></A>zsche, A. Thomassen, and T. Clausen. Effect of thyroid function on number of Na-K pumps in human skeletal muscle. Lancet ii: 8-10, 1984.

13.   Kohn, P. G., and T. Clausen. The relationship between transport of glucose and cations across cell membranes in isolated tissues. VI. The effect of insulin, ouabain and metabolic inhibitors on the transport of 3-O-methylglucose and glucose in rat soleus muscles. Biochim. Biophys. Acta 225: 277-290, 1971[Medline].

14.   Lazarus, J. H. Hyperthyroidism. Lancet 349: 339-343, 1997[Medline].

15.   Nørgaard, A., K. Kjeldsen, O. Hansen, and T. Clausen. A simple and rapid method for the determination of the number of 3H-ouabain binding sites in biopsies of skeletal muscle. Biochem. Biophys. Res. Commun. 111: 319-324, 1983[Medline].

16.   Ramsay, I. Thyroid Disease and Muscle Dysfunction. London: Heinemann, 1974.

17.   Wolitzky, B. A., and D. M. Fambrough. Regulation of the (Na+ + K+)-ATPase in cultured chick skeletal muscle. Modulation of expression by the demand for ion transport. J. Biol. Chem. 261: 9990-9999, 1986[Abstract/Free Full Text].


AJP Regul Integr Compar Physiol 274(3):R864-R867
0363-6119/98 $5.00 Copyright © 1998 the American Physiological Society



This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
A. L. D. Riis, J. O. L. Jorgensen, N. Moller, J. Weeke, and T. Clausen
Hyperthyroidism and cation pumps in human skeletal muscle
Am J Physiol Endocrinol Metab, June 1, 2005; 288(6): E1265 - E1269.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
T. CLAUSEN
Na+-K+ Pump Regulation and Skeletal Muscle Contractility
Physiol Rev, October 1, 2003; 83(4): 1269 - 1324.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. Aydemir-Koksoy and J. C. Allen
Regulation of Na+ pump expression by vascular smooth muscle cells
Am J Physiol Heart Circ Physiol, April 1, 2001; 280(4): H1869 - H1874.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
O. M. Sejersted and G. Sjogaard
Dynamics and Consequences of Potassium Shifts in Skeletal Muscle and Heart During Exercise
Physiol Rev, October 1, 2000; 80(4): 1411 - 1481.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
C. Johansson, J. Lannergren, P.-K. Lunde, B. Vennstrom, P. Thoren, and H. Westerblad
Isometric force and endurance in soleus muscle of thyroid hormone receptor-alpha 1- or -beta -deficient mice
Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2000; 278(3): R598 - R603.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
A. P. Harrison and J. A. Flatman
Measurement of force and both surface and deep M wave properties in isolated rat soleus muscles
Am J Physiol Regulatory Integrative Comp Physiol, December 1, 1999; 277(6): R1646 - R1653.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Harrison, A. P.
Right arrow Articles by Clausen, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Harrison, A. P.
Right arrow Articles by Clausen, T.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online